ADVOCATE. CONNECT. INNOVATE.

CLSA Wire

Assemblymember Wood Moves Forward on Effort to Ban Copay Coupons
Facebook
Twitter
LinkedIn

March 18, 2017

Asm. Jim Wood (D-Healdsburg), Chair of the Assembly Health Committee, is preparing Assembly Bill (AB) 265 to be heard in his committee at some time in the next month.

The bill would prohibit a drug manufacturer from offering in California “any discount, rebate, product voucher, or other reduction in an individual’s out-of-pocket expenses, including, but not limited to, a copayment or deductible” if a lower cost and therapeutically equivalent brand or generic drug is “available.”

CLSA has taken an oppose position on the bill due to its potential negative impact on patients for whom a prescriber has determined a certain brand medicine is necessary, among other reasons. We anticipate significant amendments to the bill prior to its hearing in Assembly Health Committee.

To learn more about this legislation, view our February update here. Questions? Please contact Brett Johnson, CLSA’s Senior Director of Policy and Regulatory Affairs (Bjohnson@califesciences.org).